News Focus
News Focus
icon url

Couch

07/07/16 1:32 PM

#209585 RE: Bngo #209583

I can't argue with the logic and have put forth the same many times!

Just waiting for ALO 02 PR.
icon url

dr_lowenstein

07/07/16 1:33 PM

#209586 RE: Bngo #209583

Is that different from the 27880 shares the "dentist" bought?
icon url

Bngo

07/07/16 1:42 PM

#209593 RE: Bngo #209583

He bought 27,880 shares at $0.355 and $0.345 today.
I also bought 27,888 shares at $0.355 today.

Can you HONESTLY tell me why you think Elite's SequestOx will not get approved when Pfizer's Embeda with ADT labeling has already been approved with similar technology?

SequestOx ADF will be approved...here is why I am confident of it and why I added 27,888 more shares today.

I am asking again for any solid rebuttal out there why the FDA would not approve SequestOx when it has already approved Embeda?

Has the FDA made any new rules or change the previous rules of the ADT approval process?

If the FDA has approved Pfizer's Embeda with an ADT labeling, then why wouldn't they approve Elite's SequestOx with similar Abuse Deterrent Technology?

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm419288.



FDA Approves Abuse Deterrent Labeling For EMBEDA® (Morphine Sulfate And Naltrexone Hydrochloride) Extended-Release (ER) Capsules CII

http://www.pfizer.com/news/press-release/press-release-detail/fda_approves_abuse_deterrent_labeling_for_embeda_morphine_sulfate_and_naltrexone_hydrochloride_extended_release_er_capsules_cii